Bolus administration of obestatin does not change glucose and insulin levels neither in the systemic nor in the portal circulation of the rat

Peptides

Volumn 29, Issue 12, 2008, Pages 2144-2149

  Kiewiet, Rosalie M ^a   Gauna, Carlotta ^a   van Aken, Maarten O ^a   van de Zande, Bedette ^a   van der Lely, Aart Jan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Ghrelin; Glucose; Insulin; IVGTT; Obestatin; Wistar rat

Indexed keywords

GLUCOSE; INSULIN; OBESTATIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; NONHUMAN; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; RAT; SYSTEMIC CIRCULATION;

ABDOMEN; ANIMALS; BLOOD GLUCOSE; FASTING; GLUCOSE TOLERANCE TEST; INJECTIONS, INTRAVENOUS; INSULIN; JUGULAR VEINS; MALE; PEPTIDE FRAGMENTS; PEPTIDE HORMONES; PORTAL VEIN; RATS; RATS, WISTAR;

RATTUS; RATTUS NORVEGICUS;

EID: 55949133135     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.09.011     Document Type: Article

References (31)

1. Aynsley-Green A., Biebuyck J.F., and Alberti K.G. Anaesthesia and insulin secretion: the effects of diethyl ether, halothane, pentobarbitone sodium and ketamine hydrochloride on intravenous glucose tolerance and insulin secretion in the rat. Diabetologia 9 (1973) 274-281
2. Broglio F., Arvat E., Benso A., Gottero C., Muccioli G., Papotti M., et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 86 (2001) 5083-5086
3. Chanoine J.P., Wong A.C., and Barrios V. Obestatin, acylated and total ghrelin concentrations in the perinatal rat pancreas. Horm Res 66 (2006) 81-88
4. Chartrel N., Alvear-Perez R., Leprince J., Iturrioz X., Reaux-Le Goazigo A., Audinot V., et al. Comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake". Science 315 (2007) 766 [author reply]
5. Cummings D.E. Ghrelin and the short- and long-term regulation of appetite and body weight. Physiol Behav 89 (2006) 71-84
6. Depoortere I., Thijs T., Moechars D., De Smet B., Ver Donck L., and Peeters T.L. Effect of peripheral obestatin on food intake and gastric emptying in ghrelin-knockout mice. Br J Pharmacol 153 (2008) 1550-1557
7. Gauna C., Delhanty P.J., Hofland L.J., Janssen J.A., Broglio F., Ross R.J., et al. Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J Clin Endocrinol Metab 90 (2005) 1055-1060
8. Gauna C., Kiewiet R.M., Janssen J.A., van de Zande B., Delhanty P.J., Ghigo E., et al. Unacylated ghrelin acts as a potent insulin secretagogue in glucose-stimulated conditions. Am J Physiol Endocrinol Metab 293 (2007) E697-704
9. Gauna C., Uitterlinden P., Kramer P., Kiewiet R.M., Janssen J.A., Delhanty P.J., et al. Intravenous glucose administration in fasting rats has differential effects on acylated and unacylated ghrelin in the portal and systemic circulation: a comparison between portal and peripheral concentrations in anesthetized rats. Endocrinology 148 (2007) 5278-5287
10. Gourcerol G., Coskun T., Craft L.S., Mayer J.P., Heiman M.L., Wang L., et al. Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodents. Obesity (Silver Spring) 15 (2007) 2643-2652
11. Granata R., Settanni F., Gallo D., Trovato L., Biancone L., Cantaluppi V., et al. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Diabetes 57 (2008) 967-979
12. Green B.D., Irwin N., and Flatt P.R. Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice. Peptides 28 (2007) 981-987
13. Holst B., Egerod K.L., Schild E., Vickers S.P., Cheetham S., Gerlach L.O., et al. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 148 (2007) 13-20
14. Johansen O., Vaaler S., Jorde R., and Reikeras O. Increased plasma glucose levels after Hypnorm anaesthesia, but not after Pentobarbital anaesthesia in rats. Lab Anim 28 (1994) 244-248
15. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
16. Lagaud G.J., Young A., Acena A., Morton M.F., Barrett T.D., and Shankley N.P. Obestatin reduces food intake and suppresses body weight gain in rodents. Biochem Biophys Res Commun 357 (2007) 264-269
17. Lauwers E., Landuyt B., Arckens L., Schoofs L., and Luyten W. Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem Biophys Res Commun 351 (2006) 21-25
18. Nogueiras R., Pfluger P., Tovar S., Arnold M., Mitchell S., Morris A., et al. Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 148 (2007) 21-26
19. Pan W., Tu H., and Kastin A.J. Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin. Peptides 27 (2006) 911-916
20. Ren A.J., Guo Z.F., Wang Y.K., Wang L.G., Wang W.Z., Lin L., et al. Inhibitory effect of obestatin on glucose-induced insulin secretion in rats. Biochem Biophys Res Commun 369 (2008) 969-972
21. Ross H., Johnston I.D., Welborn T.A., and Wright A.D. Effect of abdominal operation on glucose tolerance and serum levels of insulin, growth hormone, and hydrocortisone. Lancet 2 (1966) 563-566
22. Seoane L.M., Al-Massadi O., Pazos Y., Pagotto U., and Casanueva F.F. Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats. J Endocrinol Invest 29 (2006) RC13-RC15
23. Tassone F., Broglio F., Destefanis S., Rovere S., Benso A., Gottero C., et al. Neuroendocrine and metabolic effects of acute ghrelin administration in human obesity. J Clin Endocrinol Metab 88 (2003) 5478-5483
24. Thompson N.M., Gill D.A., Davies R., Loveridge N., Houston P.A., Robinson I.C., et al. Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 145 (2004) 234-242
25. van der Lely A.J., Tschop M., Heiman M.L., and Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25 (2004) 426-457
26. Vestergaard E.T., Djurhuus C.B., Gjedsted J., Nielsen S., Moller N., Holst J.J., et al. Acute effects of ghrelin administration on glucose and lipid metabolism. J Clin Endocrinol Metab 93 (2008) 438-444
27. Wren A.M., Small C.J., Ward H.L., Murphy K.G., Dakin C.L., Taheri S., et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141 (2000) 4325-4328
28. Yamamoto D., Ikeshita N., Daito R., Herningtyas E.H., Toda K., Takahashi K., et al. Neither intravenous nor intracerebroventricular administration of obestatin affects the secretion of GH, PRL, TSH and ACTH in rats. Regul Pept 138 (2007) 141-144
29. Zhang J.V., Klein C., Ren P.G., Kass S., Donck L.V., Moechars D., et al. Response to comment on obestatin, a peptide encoded by the ghrelin gene opposes ghrelin's effects on food intake. Science 315 (2007) 766
30. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310 (2005) 996-999
31. Zizzari P., Longchamps R., Epelbaum J., and Bluet-Pajot M.T. Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents. Endocrinology 148 (2007) 1648-1653